Diabetes drug slows experimental Parkinson's disease progression, human trials to begin next year
Wednesday, December 7, 2016 - 15:31
in Health & Medicine
A new investigational drug originally developed for type 2 diabetes is being readied for human clinical trials in search of the world's first treatment to impede the progression of Parkinson's disease following publication of new research.